Molecular characterization of selectively vulnerable neurons in Alzheimer’s disease
2021 · Nature Neuroscience · 444 citations
https://doi.org/10.1038/s41593-020-00764-7
K
Kun Leng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
1.9K
Citations
16
h-index
21
i10-index
Kun Leng is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Neuroinflammation and Neurodegeneration Mechanisms & Single-cell and spatial transcriptomics & Alzheimer's disease research and treatments. The author has an h-index of 16, co-authored 40 publications.
ORCID: 0000-0001-9931-1375Papers by this author
worksGenome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
2021 · Nature Neuroscience · 395 citations
https://doi.org/10.1038/s41593-021-00862-0
A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states
2022 · Nature Neuroscience · 241 citations
https://doi.org/10.1038/s41593-022-01131-4
Reactive astrocytes transduce inflammation in a blood-brain barrier model through a TNF-STAT3 signaling axis and secretion of alpha 1-antichymotrypsin
2022 · Nature Communications · 159 citations
https://doi.org/10.1038/s41467-022-34412-4
Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors
2022 · eLife · 143 citations
https://doi.org/10.7554/elife.81856
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · The Lancet Diabetes & Endocrinology · 36 citations
https://doi.org/10.1016/s2213-8587(23)00253-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat